Rethinking Psychiatric Drugs: A Guide for Informed Consent
-- Are patients aware of the fact that pharmacological therapies stress the brain in ways which may prevent or postpone symptomatic and functional recovery ?
Rethinking Psychiatric Drugs: A Guide for Informed Consent is a critical appraisal of the medications which an estimated 20% of Americans consume on a regular (and sometimes involuntary) basis.
It is the philosophically, epidemiologically, and scientifically supported revelation of how and why psychiatry’s drug therapies have contributed to a standard of care which frequently does more to harm than to cure.
Extensively researched and documented, the book addresses:
-- the process by which psychiatric drugs reach the market
-- the common flaws in research methodologies which negate the validity of the psychiatric RCT (Randomized Controlled Trial)
-- the problem of allostatic load (how drugs stress the body)
-- the history, long term effects, and utility of the drugs used to suppress symptoms of depression, psychosis, inattention and hyperactivity
-- the effectiveness of alternatives to medication
Rethinking Psychiatric Drugs: A Guide for Informed Consent exposes the current crisis in medical ethics and epistemology, and attempts to restore to psychiatry an authentically informed consent to care.